Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Jan. 30, 2018 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Dec. 31, 2017 |
[1] | |||
Other current liabilities | $ 58 | $ 58 | $ 250 | ||||||
Contingent obligation | 1,906 | 1,906 | 1,662 | ||||||
General and administrative expense | 2,145 | $ 2,414 | 6,021 | $ 4,907 | |||||
Other long-term liabilities | 84 | 84 | |||||||
Financing expense | 85 | $ 72 | 244 | $ 207 | |||||
License and Supply Agreement (Coated Products) [Member] | |||||||||
Description of royalty payment | <p style="font: 10pt Times New Roman, Times, Serif">a. 2% of the first $25 million in annual net sales of Coated Products; and</p> <p style="font: 10pt Times New Roman, Times, Serif">b. 1.5% once annual net sales exceed $25 million of Coated Products.</p> | ||||||||
Description of minimum royalty payment | <p style="font: 10pt Times New Roman, Times, Serif">a. January 1, 2020 to December 31, 2020 - $5 per calendar quarter;</p> <p style="font: 10pt Times New Roman, Times, Serif">b. January 1, 2021 to December 31, 2021 - $10 per calendar quarter;</p> <p style="font: 10pt Times New Roman, Times, Serif">c. January 1, 2022 and beyond - $15 per calendar quarter.</p> | ||||||||
Description of royalty payment for one-time milestone | <p style="font: 10pt Times New Roman, Times, Serif">a. $12.5 due 6 months after the first commercial sale of a Coated Product.</p> <p style="font: 10pt Times New Roman, Times, Serif">b. $12.5 due 12 months after the first commercial sale of a Coated Product.</p> <p style="font: 10pt Times New Roman, Times, Serif">c. $25 due 18 months after the first commercial sale of a Coated Product.</p> | ||||||||
Other current liabilities | 13 | 13 | |||||||
General and administrative expense | 0 | 50 | |||||||
Other long-term liabilities | 37 | $ 37 | |||||||
Royalty Arrangements To Israel Innovation Authority [Member] | |||||||||
Description of royalty payment | <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%">Royalties ranging from 3% to 3.5% of revenues on sales of products and services based on technology developed using IIA grants, up to an aggregate of 100% (which may be increased under certain circumstances) of the U.S. dollar-linked value of the grant, plus interest at the rate of 12-month LIBOR.</td></tr> </table> | ||||||||
Royalty received | $ 1,332 | ||||||||
Contingent obligation | $ 1,382 | $ 1,382 | |||||||
|